Who to call at SAGIMET BIOSCIENCES INC., and when
Fundz watches for the moments SAGIMET BIOSCIENCES INC. starts buying, and tells you who to reach.
- An alert the day SAGIMET BIOSCIENCES INC. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at SAGIMET BIOSCIENCES INC., from your own LinkedIn network
SAGIMET BIOSCIENCES INC.
The company signed a major contract or deal. An 8-K is the notice a US public company must file within four business days of a major event.
3vbio.comAI Executive Summary
AI-powered analysis of 8-K filing content
Sagimet Biosciences entered into an underwriting agreement on September 30, 2026, to conduct an underwritten public offering of 8.75 million shares of Series A common stock at $10.00 per share and 2.75 million pre-funded warrants at $9.9999 per share, raising approximately $87.5 million in gross proceeds to fund operational capabilities and strategic initiatives.
Key Takeaways
Sagimet is raising approximately $87.5 million through an underwritten offering of common stock and pre-funded warrants
The offering involves three underwriters: Leerink Partners LLC, TD Securities (USA) LLC, and Guggenheim Securities, LLC
2 more takeaways
Related Filings (5)
5 more filings from SAGIMET BIOSCIENCES INC. in the last 90 days
Filing Overview
What This Means
SAGIMET BIOSCIENCES INC. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.